KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 189 filers reported holding KRYSTAL BIOTECH INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,269,040 | -15.1% | 10,940 | -14.1% | 0.18% | -8.9% |
| Q2 2023 | $1,495,089 | +70.7% | 12,735 | +16.4% | 0.20% | +27.0% |
| Q1 2023 | $875,856 | +1.1% | 10,940 | 0.0% | 0.16% | -4.2% |
| Q4 2022 | $866,667 | +116.7% | 10,940 | +86.0% | 0.17% | +196.4% |
| Q2 2021 | $400,000 | – | 5,882 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 771,250 | $53,949,000 | 4.15% |
| First Light Asset Management, LLC | 680,170 | $47,578,000 | 3.41% |
| ACT CAPITAL MANAGEMENT, LLC | 59,000 | $4,127,000 | 2.98% |
| S Squared Technology, LLC | 95,215 | $6,660,000 | 2.98% |
| Redmile Group, LLC | 1,820,898 | $127,372,000 | 2.90% |
| Soleus Capital Management, L.P. | 228,437 | $15,979,000 | 1.60% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 50,922 | $3,562,000 | 1.59% |
| Artal Group S.A. | 700,000 | $48,965,000 | 1.33% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 46,670 | $3,265,000 | 1.32% |
| Kynam Capital Management, LP | 34,816 | $2,435,000 | 1.30% |